๐๐ค๐ข๐ง ๐๐ฎ๐๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐๐ฌ ๐๐๐ ๐ญ๐ก๐ ๐๐จ๐ฎ๐ง๐ ๐๐๐ซ๐ ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
As per a statement by a market research firm, P&S Intelligence, wound care biologics market is experiencing growth, and it will continue to grow in the years to come.
North America will be the leader of the industry. This has a lot to do with the increasing elderly population, innovation in wound care biologics, augmented contribution of private and public organizations in increasing consciousness on wound care, and the increasing count of burn cases.
Furthermore, the increasing occurrence of ulcers and growing keenness of patients for cutting-edge wound care products that have negligible side-effects and graft rejection are resultant in the high acceptance of wound care biologics in the region.
The industry will grow the fastest in the APAC region, mostly because of tech innovations, increasing elderly population, increasing count of burn cases and traumatic wounds, and increasing occurrence of chronic wounds. Asa per the World Population Ageing 2017, Asia witnessed a two-fold increase in its elderly population, with the people over the age of 60 years will reach to about 1.3 billion by 2050.
Additionally, as per the IDF, diabetes cases will reach 183 million by 2045. Therefore, factors for example increasing occurrence of diabetes and increasing people with obesity will contribute to the high requirement for wound care biologics
๐๐ค๐ข๐ง ๐ฌ๐ฎ๐๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐๐ฌ ๐ฅ๐๐ ๐ญ๐ก๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ง๐ ๐ฐ๐ข๐ฅ๐ฅ ๐ ๐ซ๐จ๐ฐ ๐ญ๐ก๐ ๐๐๐ฌ๐ญ๐๐ฌ๐ญ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐
This has a lot to do with the extensive usage of skin substitutes in chronic wound treatment. Human- and animal-based skin substitutes have a complete extracellular matrix construction and let the construction of natural dermis.
Furthermore, skin substitutes have excellent characteristics of re epithelialization. Also, hospitals and specialty clinics dominated the industry. The high requirement for wound care biologics in end-users is mostly because patients with chronic wounds need treatment under the direction of a trained healthcare professional.
Increasing use of permanent and temporary skin substitutes and increasing requirement for combination dressings, for instance, silver collagen and collagen hydrochloride for the prevention of microbial infection in injured areas are the main trends of the wound care biologics market.
Also, growing emphasis of pharma and biotech companies on new biologics is subsequent in the expansion of new, improved products that are providing support to the wound care specialists for the treatment of the acute and chronic wounds, which comprises of venous leg ulcers, diabetic foot ulcers, pressure ulcers, and surgical and burn injuries, in an improved way.
๐๐๐๐๐๐: ๐&๐ ๐๐ง๐ญ๐๐ฅ๐ฅ๐ข๐ ๐๐ง๐๐